The company’s revenue also jumped 5.2 percent from $151.7 million in 2012 to $159.5 million this past quarter.
Nuvasive also announced a partial settlement in the patent litigation with Medtronic. Nuvasive will pay $7.5 million to settle phase II of the litigation. The settlement resolves all disputes related to cervical plate patents and gives NuVasive broad access to Medtronic’s portfolio of cervical plate patents, according to the release.
More Articles on Devices:
20 News Updates for Orthopedic & Spine Device Companies
Alphatec Spine Gross Profits Increase 2.9% in Q1
Device Start-Up NovoSource Receives FDA Clearance for Knee Implant
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
